Comparison
20q13 33 Microdeletion Syndrome C4518823 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 20q13 33 Microdeletion Syndrome and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
20q13 33 Microdeletion Syndrome C4518823
A severe chromosomal disorder involving loss of genetic material near the end of chromosome 20. This can result in significant developmental problems and complex medical needs. Requires multidisciplinary supportive care.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
20q13 33 Microdeletion Syndrome C4518823
0-null
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
20q13 33 Microdeletion Syndrome C4518823
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
20q13 33 Microdeletion Syndrome C4518823
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
20q13 33 Microdeletion Syndrome C4518823
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
20q13 33 Microdeletion Syndrome C4518823
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
20q13 33 Microdeletion Syndrome C4518823
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
20q13-33-microdeletion-syndrome-C4518823 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 20q13 33 Microdeletion Syndrome C4518823 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Developmental problems | Described as significant developmental problems with complex needs. | Features vary and may include developmental delays. | Moderate |
| Overall clinical severity | Source classifies the condition as severe. | Source classifies the condition as moderate. | Moderate |
| Age at recognition | Onset is not established in the supplied data. | Reported onset range is 0 to 5 years. | Low |
When to favor each condition
Choose 20q13 33 Microdeletion Syndrome C4518823 when
Confirmed loss at 20q13.33
The chromosomal locus and deletion, not severity alone, define this diagnosis.
High
Complex congenital needs
The source emphasizes significant developmental problems and multidisciplinary care.
Moderate
Severity labeling only
Severe classification supports consideration but cannot replace genetic confirmation.
Low
Choose 14q11 2 Microduplication Syndrome C4749855 when
Confirmed extra material at 14q11.2
A duplication at this locus distinguishes it from a 20q deletion.
High
Variable developmental delay
The source describes variable features that may include delays.
Moderate
Presentation between birth and age 5
This onset range is supplied for the right condition, but confirmation is still required.
Low
How key tests differ
| Test | 20q13 33 Microdeletion Syndrome C4518823 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect loss involving 20q13.33. | May detect a small gain at 14q11.2. | Locus and copy-number change distinguish the findings; clinician and laboratory review is required. |
| Karyotype | A microdeletion may not be visible. | A microduplication may not be visible. | A normal karyotype does not exclude either condition. |
| Clinical genetic assessment | Supports interpretation of a severe congenital presentation. | Supports interpretation of variable, moderate features. | Assessment guides testing but is not itself diagnostic. |
Prognosis comparison
20q13 33 Microdeletion Syndrome C4518823
- Outcome
- A severe chronic course is described, but individual prognosis is not established.
- Factors
- Extent of genetic loss, developmental needs, and associated medical complexity may matter.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- A moderate chronic course with variable features is described.
- Factors
- Feature variability, developmental progress, and response to supportive care may matter.
Time frame: Lifelong monitoring is appropriate; exact milestones or survival data are not supplied.
Precise genetic result, clinical findings, and access to coordinated care should guide prognosis.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complexity | Significant developmental problems are described. Developmental delays may occur and vary. Exact complications are not established by the supplied data. |
| Medical-care needs | Complex needs and multidisciplinary supportive care are described. Supportive therapies and monitoring are the stated focus. Care intensity should be individualized by clinicians. |
| Long-term course | Described as chronic, but specific outcomes are unavailable. Described as chronic, with variable features. No mortality or complication rates are supplied. |
Patient education highlights
- HighGenetic confirmation
Diagnosis depends on identifying the specific chromosomal change and requires specialist interpretation.
- HighSupportive care
Management is supportive; no treatment dose or curative regimen is established here.
- MediumInheritance and transmission
These are congenital chromosomal conditions and are not communicable; recurrence counseling needs individual genetic review.